{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T12:52:10Z","timestamp":1787921530470,"version":"build-2784847793"},"reference-count":12,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,9,25]],"date-time":"2022-09-25T00:00:00Z","timestamp":1664064000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,9,25]],"date-time":"2022-09-25T00:00:00Z","timestamp":1664064000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004156","name":"Mahidol University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004156","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Exp Hematol Oncol"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Increasing evidence of association between kidney stone disease (KSD) and renal cell carcinoma (RCC) has been reported. Nevertheless, mechanism underlying such association remained unknown. Herein, we investigated the effects of calcium oxalate monohydrate (COM), a major crystalline component causing KSD, on induction of carcinogenic features in non-cancerous renal cells. COM crystals induced morphological changes from epithelial to fibroblast-like spindle shape. Additionally, COM increased spindle index and mesenchymal markers (fibronectin and vimentin) but declined epithelial markers (E-cadherin and zonula occludens-1). Moreover, COM down-regulated <jats:italic>ARID1A<\/jats:italic>, a tumor suppressor gene recently reported to be reversely associated with RCC, at both mRNA and protein levels. COM also down-regulated other RCC-related tumor suppressor genes, <jats:italic>PTEN<\/jats:italic> and <jats:italic>VHL<\/jats:italic>, but up-regulated oncogene <jats:italic>TPX2<\/jats:italic>. Finally, COM enhanced invading capability, cell-aggregate formation, chemoresistance to cisplatin, and secretion of an angiogenic factor (VEGF). These data indicate that COM crystals trigger epithelial-mesenchymal transition (EMT) and several carcinogenic features in the non-cancerous renal cells. These mechanisms may explain and strengthen the association between KSD and RCC.<\/jats:p>","DOI":"10.1186\/s40164-022-00320-y","type":"journal-article","created":{"date-parts":[[2022,9,25]],"date-time":"2022-09-25T06:02:19Z","timestamp":1664085739000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Calcium oxalate crystals trigger epithelial-mesenchymal transition and carcinogenic features in renal cells: a crossroad between kidney stone disease and renal cancer"],"prefix":"10.1186","volume":"11","author":[{"given":"Paleerath","family":"Peerapen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wanida","family":"Boonmark","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pattaranit","family":"Putpeerawit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Visith","family":"Thongboonkerd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,9,25]]},"reference":[{"issue":"1","key":"320_CR1","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21654","volume":"71","author":"RL Siegel","year":"2021","unstructured":"Siegel RL, Miller KD, Fuchs HE, Jemal A. Cancer statistics, 2021. CA Cancer J Clin. 2021;71(1):7\u201333. https:\/\/doi.org\/10.3322\/caac.21654.","journal-title":"CA Cancer J Clin"},{"issue":"3","key":"320_CR2","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1093\/qjmed\/hcu195","volume":"108","author":"W Cheungpasitporn","year":"2015","unstructured":"Cheungpasitporn W, Thongprayoon C, O\u2019Corragain OA, Edmonds PJ, Ungprasert P, Kittanamongkolchai W, et al. The risk of kidney cancer in patients with kidney stones: a systematic review and meta-analysis. QJM. 2015;108(3):205\u201312. https:\/\/doi.org\/10.1093\/qjmed\/hcu195.","journal-title":"QJM"},{"issue":"3","key":"320_CR3","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1038\/s41416-018-0356-7","volume":"120","author":"JAA van de Pol","year":"2019","unstructured":"van de Pol JAA, van den Brandt PA, Schouten LJ. Kidney stones and the risk of renal cell carcinoma and upper tract urothelial carcinoma: the Netherlands cohort study. Br J Cancer. 2019;120(3):368\u201374. https:\/\/doi.org\/10.1038\/s41416-018-0356-7.","journal-title":"Br J Cancer"},{"issue":"11\u201312","key":"320_CR4","doi-asserted-by":"publisher","first-page":"E716","DOI":"10.5489\/cuaj.366","volume":"7","author":"SD Chung","year":"2013","unstructured":"Chung SD, Liu SP, Lin HC. A population-based study on the association between urinary calculi and kidney cancer. Can Urol Assoc J. 2013;7(11\u201312):E716\u201321. https:\/\/doi.org\/10.5489\/cuaj.366.","journal-title":"Can Urol Assoc J"},{"issue":"2","key":"320_CR5","doi-asserted-by":"publisher","first-page":"E89","DOI":"10.5858\/2003-127-e89-RCCWIC","volume":"127","author":"NC Rioux-Leclercq","year":"2003","unstructured":"Rioux-Leclercq NC, Epstein JI. Renal cell carcinoma with intratumoral calcium oxalate crystal deposition in patients with acquired cystic disease of the kidney. Arch Pathol Lab Med. 2003;127(2):E89-92. https:\/\/doi.org\/10.5858\/2003-127-e89-RCCWIC.","journal-title":"Arch Pathol Lab Med"},{"issue":"4","key":"320_CR6","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1097\/01.pas.0000152131.58492.97","volume":"29","author":"N Sule","year":"2005","unstructured":"Sule N, Yakupoglu U, Shen SS, Krishnan B, Yang G, Lerner S, et al. Calcium oxalate deposition in renal cell carcinoma associated with acquired cystic kidney disease: a comprehensive study. Am J Surg Pathol. 2005;29(4):443\u201351. https:\/\/doi.org\/10.1097\/01.pas.0000152131.58492.97.","journal-title":"Am J Surg Pathol"},{"issue":"3","key":"320_CR7","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1111\/j.1365-2559.2010.03480.x","volume":"56","author":"Y Enoki","year":"2010","unstructured":"Enoki Y, Katoh G, Okabe H, Yanagisawa A. Clinicopathological features and CD57 expression in renal cell carcinoma in acquired cystic disease of the kidneys: with special emphasis on a relation to the duration of haemodialysis, the degree of calcium oxalate deposition, histological type, and possible tumorigenesis. Histopathology. 2010;56(3):384\u201394. https:\/\/doi.org\/10.1111\/j.1365-2559.2010.03480.x.","journal-title":"Histopathology"},{"issue":"15\u201316","key":"320_CR8","doi-asserted-by":"publisher","first-page":"1700192","DOI":"10.1002\/pmic.201700192","volume":"17","author":"A Vinaiphat","year":"2017","unstructured":"Vinaiphat A, Aluksanasuwan S, Manissorn J, Sutthimethakorn S, Thongboonkerd V. Response of renal tubular cells to differential types and doses of calcium oxalate crystals: Integrative proteome network analysis and functional investigations. Proteomics. 2017;17(15\u201316):1700192. https:\/\/doi.org\/10.1002\/pmic.201700192.","journal-title":"Proteomics"},{"issue":"5","key":"320_CR9","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1007\/s00240-014-0676-x","volume":"42","author":"W Kittikowit","year":"2014","unstructured":"Kittikowit W, Waiwijit U, Boonla C, Ruangvejvorachai P, Pimratana C, Predanon C, et al. Increased oxidative DNA damage seen in renal biopsies adjacent stones in patients with nephrolithiasis. Urolithiasis. 2014;42(5):387\u201394.","journal-title":"Urolithiasis"},{"key":"320_CR10","doi-asserted-by":"publisher","first-page":"101084","DOI":"10.1016\/j.redox.2018.101084","volume":"25","author":"US Srinivas","year":"2019","unstructured":"Srinivas US, Tan BWQ, Vellayappan BA, Jeyasekharan AD. ROS and the DNA damage response in cancer. Redox Biol. 2019;25:101084. https:\/\/doi.org\/10.1016\/j.redox.2018.101084.","journal-title":"Redox Biol"},{"key":"320_CR11","doi-asserted-by":"publisher","first-page":"593039","DOI":"10.3389\/fgene.2020.593039","volume":"11","author":"E Guo","year":"2020","unstructured":"Guo E, Wu C, Ming J, Zhang W, Zhang L, Hu G. The clinical significance of DNA damage repair signatures in clear cell renal cell carcinoma. Front Genet. 2020;11:593039. https:\/\/doi.org\/10.3389\/fgene.2020.593039.","journal-title":"Front Genet"},{"issue":"10","key":"320_CR12","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1007\/s11934-021-01066-6","volume":"22","author":"K Gillams","year":"2021","unstructured":"Gillams K, Juliebo-Jones P, Juliebo SO, Somani BK. Gender differences in kidney stone disease (KSD): findings from a systematic review. Curr Urol Rep. 2021;22(10):50. https:\/\/doi.org\/10.1007\/s11934-021-01066-6.","journal-title":"Curr Urol Rep"}],"container-title":["Experimental Hematology &amp; Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40164-022-00320-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40164-022-00320-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40164-022-00320-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,25]],"date-time":"2022-09-25T06:02:42Z","timestamp":1664085762000},"score":1,"resource":{"primary":{"URL":"https:\/\/ehoonline.biomedcentral.com\/articles\/10.1186\/s40164-022-00320-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,25]]},"references-count":12,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["320"],"URL":"https:\/\/doi.org\/10.1186\/s40164-022-00320-y","relation":{},"ISSN":["2162-3619"],"issn-type":[{"value":"2162-3619","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,25]]},"assertion":[{"value":"24 August 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 September 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 September 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"62"}}